Sign in

You're signed outSign in or to get full access.

CT

CORCEPT THERAPEUTICS (CORT)·Earnings Reports

Corcept Therapeutics Q4 2025 earnings results — revenue and EPS miss, strong 2026 guidance

Q4 2025

View earnings summary and analysis

Q3 2025

View earnings summary and analysis

Q2 2025

View earnings summary and analysis

Q1 2025

View earnings summary and analysis

Q4 2024

View earnings summary and analysis

Analyst Coverage

Research analysts covering CORCEPT THERAPEUTICS.

Recent News about CORCEPT THERAPEUTICS

Corcept Therapeutics Crashes 25% After Federal Appeals Court Clears Teva Generic
Corporate

Corcept Therapeutics Crashes 25% After Federal Appeals Court Clears Teva Generic

Feb 20
Corcept's Ovarian Cancer Drug Extends Lives by 4 Months in Pivotal Trial, Stock Whipsaws
Corporate

Corcept's Ovarian Cancer Drug Extends Lives by 4 Months in Pivotal Trial, Stock Whipsaws

Jan 23
Corcept Crashes 50% After FDA Rejects Relacorilant for Cushing's Syndrome
Corporate

Corcept Crashes 50% After FDA Rejects Relacorilant for Cushing's Syndrome

Jan 1
View all news